Editor's News Trails
Publisher-associated editorial trails will appear here when an editorial publishing workflow is available.
Publisher profile
targetals.org
Explore recent coverage from this publisher, with reporting context brought together on Scroll News.
Reporting, in context
No article image available
Antisense Oligonucleotide Tofersen Distribution in the Central Nervous System of SOD1-ALS Autopsy Tissue Donors. Guise AJ, Sellon MT, Roemer SF, Monine M, Comfort Harris NT, […] Plowey ED. JAMA Neurol. 2026 Jul 6:e262195. doi: 10.1001/jamaneurol.2026.2195. Epub ahead of print. PMID: 42406382; PMCID: PMC13338845. Using human 3D organoid models to gain mechanistic insight in motor neuron […]
$2.4 million Invested in Biomarker Innovation ALS is a heterogeneous disease with distinct subpopulations of cases clustering together based on common underlying biology and with distinct differences in the clinical time course and manifestation of disease. Biomarkers are therefore critical for enabling precision medicine to deliver the right therapy to the right individual at the […]
Basic Biology Consortium breaks new ground in ALS In 2022, Target ALS awarded funding to Drs. Jonathan Cooper-Knock (University of Sheffield, project lead) and Michael Snyder (Stanford University), along with fellow consortium members Drs. Ophir Shalem (University of Pennsylvania) and Eran Hornstein (Weizmann Institute), for their project “Exploring the landscape of ALS genetics with machine […]
Follow a story across time
Explore editorial and community perspectives on connected reporting.
Distinct perspectives · No trails available yet
Publisher-associated editorial trails will appear here when an editorial publishing workflow is available.
Public reader-created trails featuring this publisher's coverage are not shown until privacy-safe discovery is available.
Explore the reporting
Browse recurring subjects across this publisher's coverage.
Publisher-specific topics
Topic discovery is not available for this publisher yet.